Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Harmonisation in pharmacovigilance.

Edwards IR, Biriell C.

Drug Saf. 1994 Feb;10(2):93-102. Review. No abstract available.

PMID:
8011183
2.

[Drug safety: from development to clinical use].

Ovchinnikova EA, Gerasimov VB.

Antibiot Khimioter. 2006;51(6):15-22. Review. Russian. No abstract available.

PMID:
17523417
3.

[Pharmacovigilance of medicinal products in Poland--new guidelines].

Jabłecka A, Korzeniowska K, Balcer-Dymel N.

Przegl Lek. 2012;69(10):1127-8. Review. Polish.

PMID:
23421106
4.

Pharmacovigilance-related topics at the level of the International Conference on Harmonisation (ICH).

Bahri P, Tsintis P.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):377-87.

PMID:
15517542
5.

WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.

Pal SN, Duncombe C, Falzon D, Olsson S.

Drug Saf. 2013 Feb;36(2):75-81. doi: 10.1007/s40264-012-0014-6.

6.

Modern methods of pharmacovigilance: detecting adverse effects of drugs.

Norén GN, Edwards IR.

Clin Med (Lond). 2009 Oct;9(5):486-9. Review. No abstract available.

PMID:
19886114
7.

Adverse drug reactions in neonates: could we be documenting more?

Hawcutt DB, O'Connor O, Turner MA.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):807-20. doi: 10.1586/17512433.2014.956090. Epub 2014 Sep 16. Review.

PMID:
25225053
8.

[Adverse drug reaction - Definitions, risk factors and pharmacovigilance].

Krähenbühl S.

Ther Umsch. 2015 Dec;72(11-12):669-71. doi: 10.1024/0040-5930/a000735. Review. German.

PMID:
26654809
9.

Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting.

Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, Hahn EG, Levy M, Brune K, Geisslinger G.

Drug Saf. 2000 Feb;22(2):161-8.

PMID:
10672897
10.

Pharmacogenetics and pharmacovigilance.

Howland RH.

Drug Saf. 2009;32(3):265-70. doi: 10.2165/00002018-200932030-00009. No abstract available.

PMID:
19338384
11.

Adverse drug reaction reporting and pharmacovigilance of new therapeutic agents.

Haas SJ.

South Med J. 2006 Apr;99(4):325-6. No abstract available.

PMID:
16634234
12.

Medicine Safety Monitoring in Pediatric Population in India.

Kaur I, Kalaiselvan V, Singh GN.

Indian J Pediatr. 2016 May;83(5):479-80. doi: 10.1007/s12098-015-1931-z. Epub 2015 Dec 4. No abstract available.

PMID:
26634262
13.

Spontaneous reports and pharmacogenetics: the role of the pharmacovigilance centre.

van Puijenbroek E, Conemans J, van Grootheest K.

Drug Saf. 2009;32(4):357-8. doi: 10.2165/00002018-200932040-00009. No abstract available.

PMID:
19388726
14.

Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.

Aronson JK.

Expert Rev Clin Pharmacol. 2015;8(4):399-409. doi: 10.1586/17512433.2015.1049598. Epub 2015 May 27. Review.

PMID:
26018632
15.

Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use.

Hauben M, Reich L.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):479-80. Epub 2005 Jul 1. No abstract available.

PMID:
15991039
16.
17.

Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.

Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T, Arias LH.

Eur J Clin Pharmacol. 1998 Aug;54(6):483-8.

PMID:
9776440
18.

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Jaquenoud Sirot E, van der Velden JW, Rentsch K, Eap CB, Baumann P.

Drug Saf. 2006;29(9):735-68. Review.

PMID:
16944962
19.

EIDOS: a mechanistic classification of adverse drug effects.

Ferner RE, Aronson JK.

Drug Saf. 2010 Jan 1;33(1):15-23. doi: 10.2165/11318910-000000000-00000.

PMID:
20000863
20.

Promoting adverse drug reaction reporting: comparison of different approaches.

Ribeiro-Vaz I, Santos CC, Cruz-Correia R.

Rev Saude Publica. 2016;50:14. doi: 10.1590/S1518-8787.2016050006122. Epub 2016 May 3.

Supplemental Content

Support Center